22 October 2019
By Dr Wendy Winnall - PCFA Research Team
Men who are carriers of BRCA2 gene mutations have a higher risk of being diagnosed with prostate cancer. This information provides an opportunity to catch prostate cancer early for these men. The IMPACT trial has tested whether PSA testing at a younger age is useful for men with BRCA gene mutations.
To read the full article just log into the PCFA Online Community.
If you're not already a member, it is free and easy to join.